Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer
ClinicalTrials.gov study NCT01622361. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
ClinicalTrials.gov study NCT07220135. IPD Sharing: Not stated. Countries: 0. Publications: 27.
A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases
ClinicalTrials.gov study NCT05042791. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients
ClinicalTrials.gov study NCT03331601. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer
ClinicalTrials.gov study NCT02025192. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Lauren Classifications and HER2 Status in Gastric Cancer Patients
ClinicalTrials.gov study NCT01927146. IPD Sharing: Not stated. Countries: 1. Publications: 1.
HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02
ClinicalTrials.gov study NCT04040686. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
ClinicalTrials.gov study NCT05325632. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT05433480. IPD Sharing: NO. Countries: 1. Publications: 2.
Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03555877. IPD Sharing: NO. Countries: 1. Publications: 2.
Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer
ClinicalTrials.gov study NCT00712140. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
ClinicalTrials.gov study NCT00129896. IPD Sharing: Not stated. Countries: 1. Publications: 2.
NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer
ClinicalTrials.gov study NCT02030561. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab
ClinicalTrials.gov study NCT05346861. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02361112. IPD Sharing: Not stated. Countries: 1. Publications: 2.
DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT02126449. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT03535961. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03204734. IPD Sharing: NO. Countries: 1. Publications: 1.
Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients
ClinicalTrials.gov study NCT05754047. IPD Sharing: NO. Countries: 0. Publications: 1.
Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction
ClinicalTrials.gov study NCT05880160. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.